Taiwan Liposome Company, Ltd. announced that its Board of directors resolved to set up TLC Biopharmaceuticals (Japan) Company, Ltd. in Japan, which is owned 100% by the company. The capital of this subsidiary is ¥10,000,000.
Taiwan Liposome Company, Ltd.
Equities
4152
TW0004152004
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-2.59% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |